Scinovex
articleTop 10% cited

Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)

American Heart Journal · 1999 · Vol. 138(1) · pp. 78–86
Christopher M. O’ConnorWendy A. GattisBarry F. UretskyKirkwood F. AdamsSteven E. McNultySteven H. GrossmanWilliam J. McKennaFaı̈ez ZannadKarl SwedbergMihai GheorghiadeRobert M. Califf
Heart Failure Treatment and ManagementAcute Myocardial Infarction ResearchCardiac electrophysiology and arrhythmiasDobutamineMedicineRandomizationHeart failureMyocardial infarctionRandomized controlled trialCardiologyInternal medicineVasoactiveAnesthesia

MeSH terms

Survival AnalysisTreatment OutcomeAgedCardiotonic AgentsDobutamineFemaleHeart FailureHumansInfusions, IntravenousMaleMiddle AgedRiskSeverity of Illness Index
Citations
515
FWCI
6.97
field-weighted impact
References
21
Percentile
98%
vs. same field & year
Citations per year
Cited by
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.